HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets

MLA

A. Battisti, et al. HDV Can Constrain HBV Genetic Evolution in Hbsag: Implications for the Identification of Innovative Pharmacological Targets. July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f7755b30df13d067d57b457a9a97cf3&authtype=sso&custid=ns315887.

APA

A. Battisti, Alberto Spanò, G. Stornaiuolo, L. Colagrossi, Francesca Ceccherini-Silberstein, Ada Bertoli, Ilaria Lenci, Carmine Minichini, Rossana Scutari, A. Barlattani, Valentina Svicher, T. Mari, Vincenzo Malagnino, Maria De Cristofaro, Lavinia Fabeni, Nicola Coppola, Giuseppina Cappiello, Carlo Federico Perno, Massimo Marignani, … Claudio Maria Mastroianni. (2018). HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets.

Chicago

A. Battisti, Alberto Spanò, G. Stornaiuolo, L. Colagrossi, Francesca Ceccherini-Silberstein, Ada Bertoli, Ilaria Lenci, et al. 2018. “HDV Can Constrain HBV Genetic Evolution in Hbsag: Implications for the Identification of Innovative Pharmacological Targets,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f7755b30df13d067d57b457a9a97cf3&authtype=sso&custid=ns315887.